Background. MELD or MELD sodium promotes sicker patients for earlier liver transplantation (LT); the balance between pre-and post-LT outcomes is still controversial. Aim. To compare MELD and related scores' risk assessment of short-term morbidity and mortality after LT. Methods. We included only transplanted cirrhotic patients from 6/2005 to 6/2010 ( = 152). Immediate pre-LT MELD, integrated MELD (iMELD), and two MELD sodium formulas "MELD Na1" and "MELDNa2" were calculated. Results. Pre-LT scores for nonsurvivors were higher than those for survivors: MELD (28 ± 8 versus 22 ± 7, = 0.005), MELD Na1 (33 ± 8 versus 27 ± 10, = 0.039), and iMELD (51 ± 6 versus 46 ± 8, = 0.018). Patient survival assessment was performed by AUROC analysis (95% CI): MELD 0.694 (0.56-0.82; = 0.006), MELD Na1 0.682 (0.56-0.79; = 0.046), MELD Na2 0.651 (0.54-0.76; = NS), and iMELD 0.698 (0.593-0.80; = 0.022). Patients with MELD ≥25 points had longer intensive care stay (mean 10 versus 7 days, = 0.015) and longer mechanical ventilatory support (5.4 versus 1.9 days, = 0.022). Conclusions. The addition of serum sodium to MELD does not improve assessment of mortality after LT. Patients with higher MELD may preclude higher morbidity after transplantation.